Drug intelligence / Profile preview

quercetin-3-docosahexaenoic acid

Development stage
Preclinical
Lead developer
Universite Montpellier
Modality
Small Molecules
Administration
Oral
01

Overview

Quercetin-3-docosahexaenoic acid is a synthetic lipophenol hybrid molecule consisting of the flavonoid quercetin esterified with the omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) at the C-3 position. It is designed as a dual-action pharmacological entity to combat both oxidative stress and carbonyl stress (anti-COS), which are critical pathological mechanisms in neurodegenerative diseases like Alzheimer's disease. By combining the antioxidant properties of quercetin with the neuroprotective effects of DHA, the molecule aims to protect neuronal cells from the toxicity of reactive aldehydes, such as acrolein. The lipophilic nature of the DHA moiety is intended to improve the cellular uptake and bioavailability of the quercetin scaffold compared to the parent polyphenol.

Other names
Quercetin-3-O-docosahexaenoateQuercetin3-O-docosahexaenoateQuercetin 3-O-docosahexaenoateQuercetin-3-DHAQuercetin3-DHAQuercetin 3-DHAQuercetin-3-docosahexaenoic acid lipophenolQuercetin3-docosahexaenoic acid lipophenolQuercetin 3-docosahexaenoic acid lipophenol

Beyond the preview

Go deeper on quercetin-3-docosahexaenoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quercetin-3-docosahexaenoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call